Serum IP-10 in the diagnosis of latent and active tuberculosis
Journal Contribution ResearchOnline@JCUClifford, Vanessa;Tebruegge, Marc;Zufferey, Christel;Germano, Susie;Denholm, Justin;Street, Alan;McBryde, Emma;Eisen, Damon;Curtis, Nigel
Abstract
We read with interest the recent article by Wergeland et al., reporting that serum interferon-gamma inducible protein 10 (IP-10) may be a useful biomarker for differentiating between active tuberculosis (TB) and latent TB infection (LTBI), as well as for monitoring the effectiveness of anti-tuberculous therapy.1 However, a key limitation of this study was the absence of a 'sick control' group of patients with respiratory tract infections. Prompted by this finding, we analysed data from our ongoing study investigating novel biomarkers of active and latent TB.
Journal
Journal of Infection
Publication Name
N/A
Volume
71
ISBN/ISSN
1532-2742
Edition
N/A
Issue
6
Pages Count
3
Location
N/A
Publisher
W.B. Saunders
Publisher Url
N/A
Publisher Location
N/A
Publish Date
N/A
Url
N/A
Date
N/A
EISSN
N/A
DOI
10.1016/j.jinf.2015.08.001